Form EFFECT EUPRAXIA PHARMACEUTICALS
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 24, 2026 9:00 A.M. |
| Form: | F-10 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Port of Houston Activity Supports Nearly $1 Trillion in U.S. Economic Value, New Study Finds
- Hennessy Capital Investment Corp. VII Shareholders Approve Business Combination with ONE Nuclear
- Memorial Hermann Health System Deepens Partnership with Strategic Investment in PartsSource
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share